Walleye Capital’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-45,211
Closed -$8.54M 5665
2023
Q3
$9M Buy
+45,211
New +$10.7M 0.02% 639
2023
Q2
Sell
-2,540
Closed -$705K 5015
2023
Q1
$551K Buy
+2,540
New +$495K 0.01% 1631
2022
Q2
Sell
-7,494
Closed -$1.55M 2782
2022
Q1
$1.55M Buy
7,494
+5,305
+242% +$875K 0.04% 446
2021
Q4
$390K Sell
2,189
-1,556
-42% -$307K 0.01% 1113
2021
Q3
$771 Buy
3,745
+1,531
+69% +$301K 0.02% 579
2021
Q2
$420 Buy
+2,214
New +$362K 0.01% 827
2021
Q1
Sell
-12,205
Closed -$1.27K 1395
2020
Q4
$1.27K Buy
+12,205
New +$1.06M 0.08% 217

Other funds holding SWAV

Walleye Capital's SWAV Position: Q4 2023 in Review

Walleye Capital sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q4 2023, closing a stake of 45,211 shares — an estimated $8.54M sold.

Walleye Capital first reported a position in SWAV in Q4 2020 and held it in 7 quarters. The position peaked at $9M in Q3 2023. 427 funds tracked by Wall St. Rank hold SWAV as of Q4 2023.

  • Walleye Capital reported no remaining Shockwave Medical, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Walleye Capital sold 45,211 Shockwave Medical, Inc. Common Stock shares in Q4 2023, an estimated $8.54M.
  • Walleye Capital first reported a position in Shockwave Medical, Inc. Common Stock in Q4 2020 and held it in 7 quarters.
  • Walleye Capital's Shockwave Medical, Inc. Common Stock position peaked at $9M in Q3 2023.
  • 427 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q4 2023.

Based on Walleye Capital's 13F filing for Q4 2023, filed 14 Feb 2024.